RE: Half year results out next week23 Sep 2023 21:19
I have asked the following questions so far.
Can you please arrange an investor meet to bring LTH's up to speed on Yourgene products , work in the pipeline for new products and target areas to grow their offerings further.
Can you please explain to investors when we can expect to see a website that details all the products that are available commercially. It is like searching for a needle in a haystack and totally ridiculous to be told still in development.
When will you give the market an R&D update, my preference is to know what I am investing in. How are the Biosensers progressing?
Why has a CEO still not been appointed and are you actively searching for one ?
Are you looking to make a further acquisition prior to June 2024 ?
Can you please provide details of your marketing campaign for Winterplex, all we as investors see are a few posts on linked in. These products should be able to generate substantial sums of cash and it would appear to me that we have to date and continue to fail to penetrate the market. Why ?
Reading about the latest Variant and the US reverting back to free LFTs for all US citizens between Nov 23 and April 24 , what is the opinion of the board with regards to manufacturing the Novacyt self test oral LFT ?
I cannot find it anywhere for sale and investor relations do not answer any questions relating to this. So few have CTDA approval , surely hospitals would prefer this on all paediatric & geriatric wards. Are you making any attempts to sell the product ?
You are a million miles away from reaching your target for organic and acquisitive growth. What exactly do you intend doing to try and accelerate this in the immediate future?
Obviously it is extremely difficult to attract funds and any form of investment from institutions with the legal proceedings looming , can you inform us if any effort whatsoever is being made to address this ?
All I have seen is them closing out positions.
However they did not all do so immediately after the news was announced re legal proceedings , whilst some may have held for the potential upside of early settlement , I cannot help but feel your refusal to uptake the market clearly with a strategy and regular progress reports is also partially to blame.
Much as I dislike over ramped statements, aim is sentiment driven and your deliberate silence is a huge part of the problem. If potential holders understood the direction of travel , perhaps some would join on the journey.
I think the time has arrived ( many believe long overdue ) that you meet investors face to face.
Why not hold a town hall type meeting and address questions put to you ?
I expect very few if any to be answered, but hey gotta give it a go .